Point-of-Care Molecular Diagnostics Market to Surge to USD 11.1 Billion by 2033, Growing at a 9.7% CAGR

The global point-of-care molecular diagnostics market is poised for remarkable growth, with an estimated valuation of USD 4.4 billion in 2023. By 2033, the market is projected to reach USD 11.1 billion, representing a robust compound annual growth rate (CAGR) of 9.7% over the forecast period. This growth underscores the increasing demand for rapid, accurate, and accessible diagnostic solutions in the healthcare industry.

https://www.futuremarketinsigh....ts.com/reports/point